ABCB1 p.Cys1074Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 10581363
[PubMed]
Ueda K et al: "Comparative aspects of the function and mechanism of SUR1 and MDR1 proteins."
No.
Sentence
Comment
467
8-Azido-ATP binding with the wild-type MDR1 was inhibited by 100 WM NEM, while 8-azido-ATP binding with the C431A/C1074A mutant form was not, suggesting that the cysteines of Walker A motifs in both NBFs are responsible for the e¡ects of NEM on ATP binding.
X
ABCB1 p.Cys1074Ala 10581363:467:28
status: NEWX
ABCB1 p.Cys1074Ala 10581363:467:114
status: NEW469 However, ATP-binding to the C1074A mutant form was signi'cantly reduced by the same treatment, similar to the wild-type MDR1.
X
ABCB1 p.Cys1074Ala 10581363:469:28
status: NEW465 8-Azido-ATP binding with the wild-type MDR1 was inhibited by 100 WM NEM, while 8-azido-ATP binding with the C431A/C1074A mutant form was not, suggesting that the cysteines of Walker A motifs in both NBFs are responsible for the e&#a1;ects of NEM on ATP binding.
X
ABCB1 p.Cys1074Ala 10581363:465:114
status: NEW
PMID: 9733949
[PubMed]
Takada Y et al: "Non-equivalent cooperation between the two nucleotide-binding folds of P-glycoprotein."
No.
Sentence
Comment
51
The C431A/C1074A double-mutant form of P-glycoprotein, in which the cysteine residues of the WA motif in both NBFs were replaced by alanine, trapped nucleotides even after treatment with 100 WM NEM (Fig. 1B).
X
ABCB1 p.Cys1074Ala 9733949:51:10
status: NEW52 Also, these cysteine-to-alanine mutations did not a¡ect the function of P-glycoprotein, because the pattern and degree of multidrug resistance conferred by the C431A/ C1074A double-mutant form were similar to those conferred by the wild-type protein (data not shown).
X
ABCB1 p.Cys1074Ala 9733949:52:172
status: NEW53 By contrast, vanadate-induced nucleotide trapping of the C431A and C1074A mutant forms, in which the cysteine residue of the WA motif in only one of the NBFs was replaced by alanine, was a¡ected by NEM (Fig. 1C,D).
X
ABCB1 p.Cys1074Ala 9733949:53:67
status: NEW54 Nucleotide trapping with the C431A mutant form was inhibited by 10 WM NEM (Fig. 1C), and nucleotide trapping with the C1074A mutant form was inhibited by 50 WM NEM (Fig. 1D).
X
ABCB1 p.Cys1074Ala 9733949:54:118
status: NEW56 E¡ects of NEM on vanadate-induced nucleotide trapping in P-glycoprotein. Plasma membrane proteins (about 20 Wg) from stable KB-3-1 transfectants expressing equivalent amounts of the wild-type human P-glycoprotein (A), the C431A/C1074A double-mutant form, in which the cysteine residues of Walker A in both NBFs were replaced by alanine (B), or the C431A (C) or C1074A (D) single-mutant form were treated with NEM at 1 WM (lane 2), 10 WM (lane 3), 50 WM (lane 4), or 100 WM (lane 5), or with NEM (lane 1).
X
ABCB1 p.Cys1074Ala 9733949:56:233
status: NEWX
ABCB1 p.Cys1074Ala 9733949:56:366
status: NEW61 A, P-glycoprotein-S; B, C431A/C1074A; C, C431A; D, C1074A. Experiments were done in duplicate.
X
ABCB1 p.Cys1074Ala 9733949:61:30
status: NEWX
ABCB1 p.Cys1074Ala 9733949:61:51
status: NEW64 P-Glycoprotein-S was labeled by 5 WM biotin maleimide and speci'cally inhibited by the presence of 100 WM NEM (Fig. 2A), but the C431A/C1074A mutant form was labeled little if at all (Fig. 2B).
X
ABCB1 p.Cys1074Ala 9733949:64:135
status: NEW65 The C431A and C1074A mutant forms were also both labeled in an NEM-dependent manner by biotin maleimide (Fig. 2C,D), suggesting that biotin maleimide at a concentration of 5 WM specifically and uniformly labels the WA cysteines in both NBFs, as previously reported [16].
X
ABCB1 p.Cys1074Ala 9733949:65:14
status: NEW70 8-Azido-ATP binding with the C431A/C1074A mutant form was not inhibited by 100 WM NEM, but possibly increased (Fig. 3B), whereas 8-azido-ATP binding of the C431A mutant form appeared not to be a¡ected (Fig. 3C).
X
ABCB1 p.Cys1074Ala 9733949:70:35
status: NEW71 However, ATP binding to the C1074A mutant form was signi'cantly reduced by treatment with 100 WM NEM (Fig. 3D), similar to the wild-type P-glycoprotein.
X
ABCB1 p.Cys1074Ala 9733949:71:28
status: NEW77 A, P-glycoprotein-S; B, C431A/C1074A; C, C431A; D, C1074A. Experiments were done in triplicate. Fig. 4.
X
ABCB1 p.Cys1074Ala 9733949:77:30
status: NEWX
ABCB1 p.Cys1074Ala 9733949:77:51
status: NEW94 The C431A/C1074A mutant form of P-glycoprotein was indistinguishable from the wild-type in its function.
X
ABCB1 p.Cys1074Ala 9733949:94:10
status: NEW95 Also the C431A/C1074A mutant P-glycoprotein trapped nucleotides even after treatment with 100 WM NEM, indicating that the other 've cysteines were probably not accessible to NEM.
X
ABCB1 p.Cys1074Ala 9733949:95:15
status: NEW97 However, the C431A/C1074A mutant P-glycoprotein showed an increase in ATP binding after NEM treatment (Fig. 3B), indicating that NEM modi'cation of other cysteine residues outside NBFs may allosterically a¡ect ATP binding in a positive manner.
X
ABCB1 p.Cys1074Ala 9733949:97:19
status: NEW111 However, NEM treatment signi'cantly reduced 8-azido-ATP binding in the C1074A mutant P-glycoprotein.
X
ABCB1 p.Cys1074Ala 9733949:111:71
status: NEW